Table 3.

Patient survival, neurological outcomes, and medical cost

	All (n = 1660)	WLST (n = 510)	No WLST (n = 1150)	p-value
Survival at 30 days, n (%)	422/1646 (25.6)	36/506 (7.1)	386/1140 (33.8)	< 0.001
Favorable neurological outcome at 30 days, n (%)a	214/1646 (13.0)	0/506 (0)	214/1140 (18.7)	< 0.001
Medical cost during hospitalization ($), median [IQR]b	23,000 [10,000–38,000]	21,000 [10,000–31,000]	24,000 [11,000–43,000]	< 0.001

WLST withholding/withdrawal of life-sustaining therapy. ^aFavorable neurological outcome was defined as Cerebral Performance Category score of 1 or 2. ^bMedical cost was converted from Yen to US Dollars (1$ = 100 Yen). Survival data missing for 14 patients. Neurological outcome data missing for 14 patients. Medical cost during hospitalization missing for 89 patients